What Does 'Compounded GLP-1' Mean?
Compounded GLP-1 products are not FDA-approved and do not undergo FDA premarket review; their lawful use depends on applicable compounding conditions and individual patient needs.
What matters
FDA says compounded drugs should only be used when a patient's medical needs cannot be met by an FDA-approved drug.
Semaglutide and tirzepatide are not currently on FDA's shortage list.
Practical checks
FDA has warned about dosing errors, fraudulent labels, misleading marketing and some shipping/storage problems involving compounded GLP-1 products.
Patients should verify the prescriber, pharmacy, exact preparation, dose instructions and storage requirements.
Sources
- HealthRX pricing
- HealthRX FAQ
- FDA: concerns with unapproved GLP-1 drugs
- FDA: 2026 compounding policy clarification
- FDA Wegovy prescribing information
- FDA Zepbound prescribing information
Provider prices and policies can change. We date-check unstable facts and distinguish provider claims from FDA or prescribing-information sources.